Primary Liver Cancers: Connecting the Dots of Cellular Studies and Epidemiology with Metabolomics

6Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Liver cancers are rising worldwide. Between molecular and epidemiological studies, a research gap has emerged which might be amenable to the technique of metabolomics. This review investigates the current understanding of liver cancer’s trends, etiology and its correlates with existing literature for hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA) and hepatoblastoma (HB). Among additional factors, the literature reports dysfunction in the tricarboxylic acid metabolism, primarily for HB and HCC, and point mutations and signaling for CCA. All cases require further investigation of upstream and downstream events. All liver cancers reported dysfunction in the WNT/β-catenin and P13K/AKT/mTOR pathways as well as changes in FGFR. Metabolites of IHD1, IDH2, miRNA, purine, Q10, lipids, phosphatidylcholine, phosphatidylethanolamine, acylcarnitine, 2-HG and propionyl-CoA emerged as crucial and there was an attempt to elucidate the WNT/β-catenin and P13K/AKT/mTOR pathways metabolomically.

Cite

CITATION STYLE

APA

Berkemeyer, S. (2023, February 1). Primary Liver Cancers: Connecting the Dots of Cellular Studies and Epidemiology with Metabolomics. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms24032409

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free